RecruitingNot Applicable

Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era

Switzerland550 participantsStarted 2021-01-01

Plain-language summary

The investigators' primary objective is to assess whether a difference in the occurrence of bleeding events exist between patients with LVT treated with DOACs as compared to those treated with VKAs.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients at least 18 years old at enrolment * With a LVT identified at echocardiography, MRI or CT between January 1st, 2013 and July 31st, 2020 * Treated at least once at the Inselspital or in another site of the Insel Gruppe * Able to provide a written informed consent Exclusion Criteria: * Documented refusal

What they're measuring

The occurrence at 1 year of bleeding

Timeframe: 1 year

Trial details

NCT IDNCT05028777

SponsorInsel Gruppe AG, University Hospital Bern

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-02-28

Contact for this trial

Christoph Gräni, Prof. PHD

+41 31 632 4508 christoph.graeni@insel.ch

View on ClinicalTrials.gov More Thrombus of Left Ventricle trials